Javascript must be enabled to continue!
Are re-admissions with acute exacerbation of chronic obstructive pulmonary disease coded correctly?
View through CrossRef
Background:
Re-admissions are common and challenging for hospitals across the UK. They not only affect patients but also have financial implications for trusts. A hospital re-admission with the same clinical condition within 30 days of discharge incurs no payment. Acute exacerbation of chronic obstructive pulmonary disease (COPD) is well recognised as a cause of recurrent admissions. We have reviewed the re-admissions to our trust in a cohort of patients with COPD.
Methods:
Retrospective review of consecutive patients coded as re-admissions within 30 days with acute COPD exacerbation between September 2012 and April 2013. Electronic patient records were used to review both the index (first) admission and re-admission episodes.
Results:
A total of 915 patients were admitted with COPD during the 8 months. Of these, 135 were coded as re-admissions. On review of discharge diagnoses, 77 patients were coded correctly on the index admission and 115 on the re-admission episode. A total of 78 patients were incorrectly coded, 58 on the index admission and 20 on re-admission. 73 (54%) of the 135 coded re-admissions were identified as definite re-admissions. The remaining 62 (46%) were not re-admitted within 30 days of the first admission and thus incorrectly coded.
Conclusion:
Almost 50% of patients coded as re-admissions with acute exacerbation of COPD were inaccurate. Clinical coding needs to improve in order to minimise and avoid financial penalties.
European Respiratory Society (ERS)
Title: Are re-admissions with acute exacerbation of chronic obstructive pulmonary disease coded correctly?
Description:
Background:
Re-admissions are common and challenging for hospitals across the UK.
They not only affect patients but also have financial implications for trusts.
A hospital re-admission with the same clinical condition within 30 days of discharge incurs no payment.
Acute exacerbation of chronic obstructive pulmonary disease (COPD) is well recognised as a cause of recurrent admissions.
We have reviewed the re-admissions to our trust in a cohort of patients with COPD.
Methods:
Retrospective review of consecutive patients coded as re-admissions within 30 days with acute COPD exacerbation between September 2012 and April 2013.
Electronic patient records were used to review both the index (first) admission and re-admission episodes.
Results:
A total of 915 patients were admitted with COPD during the 8 months.
Of these, 135 were coded as re-admissions.
On review of discharge diagnoses, 77 patients were coded correctly on the index admission and 115 on the re-admission episode.
A total of 78 patients were incorrectly coded, 58 on the index admission and 20 on re-admission.
73 (54%) of the 135 coded re-admissions were identified as definite re-admissions.
The remaining 62 (46%) were not re-admitted within 30 days of the first admission and thus incorrectly coded.
Conclusion:
Almost 50% of patients coded as re-admissions with acute exacerbation of COPD were inaccurate.
Clinical coding needs to improve in order to minimise and avoid financial penalties.
Related Results
Anxiety-depressive syndrome in patients with arterial hypertension and chronic obstructive pulmonary disease with frequent exaccations
Anxiety-depressive syndrome in patients with arterial hypertension and chronic obstructive pulmonary disease with frequent exaccations
Background. In patients with frequent exacerbations of chronic obstructive pulmonary disease occurring against the background of hypertension, there is a high level of personal neu...
Prevalence of depression and anxiety in patients with chronic obstructive pulmonary disease and their association with psychosocial outcomes: A cross-sectional study from Pakistan
Prevalence of depression and anxiety in patients with chronic obstructive pulmonary disease and their association with psychosocial outcomes: A cross-sectional study from Pakistan
Objectives:
Chronic obstructive pulmonary disease contributes to substantial health and economic burden worldwide. Co-morbid depression and anxiety are highly p...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
The lung microbiome and chronic obstructive pulmonary disease: a contemporary perspective on the issue
The lung microbiome and chronic obstructive pulmonary disease: a contemporary perspective on the issue
Background. Chronic obstructive pulmonary disease remains a significant public health problem. Exacerbations of сhronic obstructive pulmonary disease, often caused by bacterial col...
DYSLIPIDEMIA AS RISK FACTOR OF ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
DYSLIPIDEMIA AS RISK FACTOR OF ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Introduction: Atherosclerosis is one of the most common co-morbidities observed in chronic obstructive pulmonary disease. A better understanding of mechanisms of
atherosclerosis in...
Dispelling Myths and Misconceptions about Chronic Obstructive Pulmonary Disease
Dispelling Myths and Misconceptions about Chronic Obstructive Pulmonary Disease
Introduction: Chronic obstructive pulmonary disease is one of the major causes of disability and mortality in the world. Despite better efforts to understand this disease, there ar...
Clinical efficacy of acupoint application of Chinese herbal medicine to prevent acute exacerbation of stable chronic obstructive pulmonary disease: A study protocol for a randomized placebo-controlled trial
Clinical efficacy of acupoint application of Chinese herbal medicine to prevent acute exacerbation of stable chronic obstructive pulmonary disease: A study protocol for a randomized placebo-controlled trial
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a major public health problem that severely affects the quality of life of patients and may even endang...

